Seed · 2026-11-17 · Healthcare
Commit Biologics raises $58.3M
69
AI Score
Amount
$58.3M
Round
Seed
Lead
Ackermans & van Haaren
HQ
Copenhagen, DK
Why it matters: Commit Biologics' €54M seed round shows investors backing a complement-based immunotherapy platform that works without T cells, a contrast to the T cell engagers and cell therapies that dominate the field.
Copenhagen-based Commit Biologics raised €54 million ($60 million) in seed funding led by Ackermans & van Haaren.
- Participants:
- AbbVie Ventures, M Ventures, Bioqube Ventures, Korys, Novo Holdings
- Source:
- EU-Startups ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Commit Biologics
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
Recent Healthcare rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing